Recent advances in proteome‐wide label‐free target deconvolution for bioactive small molecules-Reference-Cited by-同舟云学术

Recent advances in proteome‐wide label‐free target deconvolution for bioactive small molecules

Published:2021-02-03 Issue:6 Volume:41 Page:2893-2926
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Sun Jichao¹²,Prabhu Nayana³,Tang Jun¹⁴,Yang Fan²⁴,Jia Lin⁵,Guo Jinan¹,Xiao Kefeng¹,Tam Wai Leong⁶⁷⁸⁹,Nordlund Pär³¹⁰^ORCID,Dai Lingyun¹²³^ORCID

Affiliation:

1. Department of Urology Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen Urology Minimally Invasive Engineering Center Shenzhen Guangdong China

2. Department of Geriatrics Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology) Shenzhen Guangdong China

3. Institute of Molecular and Cell Biology Agency for Science, Technology and Research (A*STAR) Singapore Singapore

4. Integrated Chinese and Western Medicine Postdoctoral Research Station Jinan University Guangzhou Guangdong China

5. College of Pharmacy Shenzhen Technology University Shenzhen Guangdong China

6. Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR) Singapore Singapore

7. Cancer Science Institute of Singapore National University of Singapore Singapore Singapore

8. Department of Biochemistry, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

9. School of Biological Sciences Nanyang Technological University Singapore Singapore

10. Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

Funder

National Natural Science Foundation of China

National Medical Research Council

Cancerfonden

Vetenskapsrådet

Knut och Alice Wallenbergs Stiftelse

National Research Foundation Singapore

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21788

Reference129 articles.

1. A comprehensive map of molecular drug targets

2. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival

3. Corpora non agunt nisi fixata. Maxim behind all of Ehrlich's great discoveries;Pelner L;N Y State J Med,1972

4. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

5. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma;Acta Pharmacologica Sinica;2023-10-06

2. Intracellular spatiotemporal metabolism in connection to target engagement;Advanced Drug Delivery Reviews;2023-09

3. Discovery and validation of PURA as a transcription target of 20(S)-protopanaxadiol: Implications for the treatment of cognitive dysfunction;Journal of Ginseng Research;2023-09

4. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products;Phytomedicine;2023-07

5. Label-free target protein characterization for small molecule drugs: recent advances in methods and applications;Journal of Pharmaceutical and Biomedical Analysis;2023-01